Collin P, Pukkala E, Reunala T
Medical School, University of Tampere, Finland.
Gut. 1996 Apr;38(4):528-30. doi: 10.1136/gut.38.4.528.
Dermatitis herpetiformis is a lifelong, gluten sensitive skin disease. Patients with dermatitis herpetiformis, similar to patients with coeliac disease not adhering to a gluten free diet, seem to have increased risk for lymphoma.
This study looked at the occurrence of malignancy and survival of patients with dermatitis herpetiformis and compared the results with those seen in patients with coeliac disease or in the general population.
A total of 305 adult patients with dermatitis herpetiformis diagnosed at the University Hospital of Tampere in 1970-1992 were studied. Most patients started a gluten free diet and at the end of the study 93% of the patients were adhering to the diet. A control group comprised 383 adult patients with coeliac disease, 81% of them adhered to a gluten free diet, 6% had a normal diet, and in 13% the diet history remained unknown.
The occurrence of malignant diseases and survival of the patients were assessed up to the end of 1993. Standardised incidence ratios (SIR) with 95% confidence intervals were used for the malignant diseases. The survival of the patients was compared with that of the general population.
Thirteen (4.3%) patients with dermatitis herpetiformis developed 14 malignant disorders during the follow up (SIR 1.25; 95% confidence intervals 0.68 to 2.09). A non-Hodgkin's lymphoma occurred in four patients with dermatitis herpetiformis, significantly more than expected (SIR 10.3; 2.8-26.3). Thirteen (4.3%) patients with dermatitis herpetiformis died during the follow up but there was no increased general mortality. In coeliac disease, 13 (3.4%) patients developed malignancy (SIR 1.16; 0.62 to 1.97), 31 (8.1%) patients died but the survival rate did not differ from that in the general population.
The incidence of non-Hodgkin's lymphoma was significantly increased in patients with dermatitis herpetiformis. The results also confirm that the patients with dermatitis herpetiformis treated mainly with a gluten free diet have no increased general mortality.
疱疹样皮炎是一种终身性的、对麸质敏感的皮肤病。与未坚持无麸质饮食的乳糜泻患者类似,疱疹样皮炎患者似乎患淋巴瘤的风险增加。
本研究观察了疱疹样皮炎患者的恶性肿瘤发生情况和生存率,并将结果与乳糜泻患者或普通人群的情况进行比较。
对1970年至1992年在坦佩雷大学医院诊断出的305例成年疱疹样皮炎患者进行了研究。大多数患者开始采用无麸质饮食,在研究结束时,93%的患者坚持该饮食。一个对照组包括383例成年乳糜泻患者,其中81%坚持无麸质饮食,6%饮食正常,13%的饮食史不明。
评估患者至1993年底的恶性疾病发生情况和生存率。恶性疾病采用标准化发病比(SIR)及95%置信区间。将患者的生存率与普通人群的生存率进行比较。
13例(4.3%)疱疹样皮炎患者在随访期间发生了14种恶性疾病(SIR 1.25;95%置信区间0.68至2.09)。4例疱疹样皮炎患者发生了非霍奇金淋巴瘤,明显多于预期(SIR 10.3;2.8 - 26.3)。13例(4.3%)疱疹样皮炎患者在随访期间死亡,但总体死亡率没有增加。在乳糜泻患者中,13例(3.4%)发生了恶性肿瘤(SIR 1.16;0.62至1.97),31例(8.1%)患者死亡,但生存率与普通人群无差异。
疱疹样皮炎患者中非霍奇金淋巴瘤的发病率显著增加。结果还证实,主要采用无麸质饮食治疗的疱疹样皮炎患者总体死亡率没有增加。